1.
Dhone Pravin G, Rahul G, Padmini S, Mubeen MF. To evaluate the efficacy and safety profile of Rosuvastatin, Simvastatin and Atorvastatin in newly diagnosed type 2 diabetic patients with dyslipidaemia. Int. J. of Health Sci. [Internet]. 2022 Jun. 30 [cited 2024 Aug. 20];6(S4):5658-66. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/10009